Testosterone & Testosterone Replacement Therapy (TRT) | Dr. Peter Attia & Dr. Andrew Huberman

Summary

Dr. Andrew Huberman and Dr. Peter Attia discuss how to think about testosterone replacement therapy (TRT). They emphasize that it should not be pursued casually for cosmetic reasons—especially by younger men—without first considering health habits, symptoms, and appropriate medical evaluation.

Key points and strategies

• Address foundational health factors first. Huberman suggests prioritizing adequate sleep, appropriate exercise and nutrition, and social connection before turning to testosterone. Attia notes an important exception: hormone levels can sometimes be low enough to make those healthy behaviors difficult, so each situation needs individual assessment.
• Assess symptoms and lab results, not just total testosterone. The speakers distinguish total testosterone from free testosterone, the portion not bound to proteins. Attia says free testosterone is his main treatment metric, with estradiol also important. They discuss a rough benchmark of free testosterone being around 2% of total testosterone, while stressing that lab results and clinical context matter.
• Look for factors affecting SHBG. Sex hormone-binding globulin (SHBG) can bind testosterone and reduce the free fraction. Attia says genetics, estradiol, insulin, and thyroid hormone (thyroxine) can influence SHBG. For example, lower insulin may raise SHBG, potentially lowering free testosterone if total testosterone does not rise.
• Investigate causes before choosing treatment. Attia describes distinguishing a problem with the pituitary’s hormonal signal (“central”) from a problem with the testes’ ability to produce testosterone (“peripheral”). He says a fertility drug such as clomiphene may be considered in some men whose testes can still respond to that signal; direct testosterone replacement is another approach.
• Treat estradiol carefully. The discussion warns against assuming that lower estrogen is always better. Driving estradiol too low may cause problems such as joint pain, memory issues, reduced libido, and increased fat accumulation. Attia says aromatase inhibitors should be used cautiously and only when appropriate.
• Discuss dosing frequency with a clinician. Attia favors dividing testosterone into more frequent doses rather than giving a large dose every two weeks. He says twice-weekly dosing is often sufficient in his practice. This is presented as a clinical approach, not a self-treatment recommendation.
• Be cautious about drugs and supplements used to manipulate hormones.
  • Attia says he no longer uses Anavar to lower SHBG, citing its complexity and a patient’s increased liver-test results after swallowing it. Huberman and Attia explicitly say this is not a recommendation; they also note potential sport bans and fertility risks.
  • Huberman says the evidence and mechanisms for tongkat ali’s effects on SHBG are uncertain. He also reports that stinging nettle lowered his DHT enough that he stopped taking it.
  • They discuss DHT’s possible relevance to sexual and mood effects, while also noting that prostate size can be a concern.
• Use medical supervision. Both speakers criticize overly aggressive or poorly monitored TRT practices, particularly high-dose injections paired with excessive aromatase inhibitors. Attia notes that testicular atrophy can occur with testosterone treatment.

Takeaway: TRT decisions should be based on symptoms, appropriate testing, the likely cause of low testosterone, and individualized medical care—not solely on a total testosterone number or cosmetic goals.

This is a summary of the conversation, not medical advice. Hormone treatment and related medications should be discussed with a qualified clinician.

Presenters and sources mentioned

• Presenters: Dr. Andrew Huberman and Dr. Peter Attia.
• Research referenced in the discussion: A study of testosterone, estradiol, and body-composition outcomes described as published in the New England Journal of Medicine; a study of testosterone, insulin resistance, and glucose disposal in prediabetic men; and a review of tongkat ali. The subtitles do not provide titles or authors for these studies or the review.